Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 5
1989 2
1990 2
1991 1
1992 3
1993 5
1994 4
1995 1
1996 4
1997 4
1998 3
1999 3
2000 6
2001 4
2002 5
2003 9
2004 9
2005 11
2006 12
2007 10
2008 15
2009 10
2010 12
2011 15
2012 19
2013 20
2014 24
2015 42
2016 45
2017 62
2018 68
2019 56
2020 61
2021 82
2022 58
2023 75
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

667 results

Results by year

Filters applied: . Clear all
Page 1
Global burden of liver disease: 2023 update.
Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Devarbhavi H, et al. J Hepatol. 2023 Aug;79(2):516-537. doi: 10.1016/j.jhep.2023.03.017. Epub 2023 Mar 27. J Hepatol. 2023. PMID: 36990226 Review.
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, Jou JH, Kulik LM, Agopian VG, Marrero JA, Mendiratta-Lala M, Brown DB, Rilling WS, Goyal L, Wei AC, Taddei TH. Singal AG, et al. Hepatology. 2023 Dec 1;78(6):1922-1965. doi: 10.1097/HEP.0000000000000466. Epub 2023 May 22. Hepatology. 2023. PMID: 37199193 No abstract available.
Hepatocellular carcinoma.
Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, Gores G. Llovet JM, et al. Nat Rev Dis Primers. 2016 Apr 14;2:16018. doi: 10.1038/nrdp.2016.18. Nat Rev Dis Primers. 2016. PMID: 27158749 Free article. Review.
Pathogenesis of Alcoholic Liver Disease.
Dunn W, Shah VH. Dunn W, et al. Clin Liver Dis. 2016 Aug;20(3):445-56. doi: 10.1016/j.cld.2016.02.004. Epub 2016 Mar 28. Clin Liver Dis. 2016. PMID: 27373608 Free PMC article. Review.
Aberrant lipid metabolism as a therapeutic target in liver cancer.
Pope ED 3rd, Kimbrough EO, Vemireddy LP, Surapaneni PK, Copland JA 3rd, Mody K. Pope ED 3rd, et al. Expert Opin Ther Targets. 2019 Jun;23(6):473-483. doi: 10.1080/14728222.2019.1615883. Epub 2019 May 10. Expert Opin Ther Targets. 2019. PMID: 31076001 Free PMC article. Review.
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference.
Llovet JM, Villanueva A, Marrero JA, Schwartz M, Meyer T, Galle PR, Lencioni R, Greten TF, Kudo M, Mandrekar SJ, Zhu AX, Finn RS, Roberts LR; AASLD Panel of Experts on Trial Design in HCC. Llovet JM, et al. Hepatology. 2021 Jan;73 Suppl 1:158-191. doi: 10.1002/hep.31327. Epub 2020 Sep 9. Hepatology. 2021. PMID: 32430997 Review. No abstract available.
AASLD guidelines for the treatment of hepatocellular carcinoma.
Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA. Heimbach JK, et al. Hepatology. 2018 Jan;67(1):358-380. doi: 10.1002/hep.29086. Hepatology. 2018. PMID: 28130846 No abstract available.
667 results